Effectiveness of Ciprofloxacin and Levofloxacin in treatment of Pseudomonas Aeruginosa infection
Keywords:Pseudomonas, oral medication, culture and sensitivity, resistance
AbstractBackground: Pseudomonas aeruginosa is the most troublesome and feared pathogen in medical field. It is the sixth most
common cause of hospital-acquired infections and the cause of ventilator-associated pneumonia. The most common multidrugresistant
gram-negative pathogen in Ventilated Assisted Patient. In our study in 100 patients culture and sensitivity report only 46%
were sensitive to oral treatment while 54% of the pseudomonas were resistant to ciprofloxacin and 34% sensitive and 66%
resistant to levofloxacin.
Objective: To find out resistance of pseudomonas to oral medication.
Material and Methods: A cross-sectional study, conducted in Saidu Group of Teaching Hospital from January 2018 to July 2019. ).
100 patient samples (tracheal aspirate, bronchial washing, sputum, pus, urine and blood) were cultured for pseudomonas and its
sensitivity to oral medication ciprofloxacin and levofloxacin was recorded.
Results: Sensitivity to 46% were samples was observed to oral treatment while 54% of the pseudomonas were resistant to
ciprofloxacin and 34% sensitive and 66% resistant to levofloxacin respectively.
Conclusion: It was found that 54% pseudomonas were resistant to Ciprofloxacin and 66% resistant to levofloxacin. So we should
always consider for combination therapy.
How to Cite
Work published in JSMC is licensed under a
The work published in Journal of Saidu Medical College is Open access, authors retain copyright and full publishing rights. The authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.